Plain-English reading on the vagus nerve, its science and how to look after it
How It Works

The Auricular Branch of Vagus Nerve: Anatomy, Arnold’s Reflex, and taVNS

A flat folk-art vector illustration of a human ear silhouette against poppies, tulips and olive sprigs on white.

The auricular branch of the vagus nerve (ABVN), also called Arnold’s nerve, is a small sensory branch that innervates part of the external ear. Despite its modest size, this branch has become the focus of intense research interest because it provides a non-invasive access point for stimulating the vagus nerve. Transcutaneous auricular vagus nerve stimulation (taVNS), which delivers mild electrical pulses to the ear, is being studied as a treatment for depression, epilepsy, chronic pain, and inflammatory conditions. This article covers the anatomy of the ABVN, Arnold’s nerve cough reflex, the science behind taVNS, and where the clinical evidence currently stands.

Anatomy of the Auricular Branch

The ABVN originates from the superior (jugular) ganglion of the vagus nerve, which sits just below the jugular foramen at the base of the skull. From there, it passes through the mastoid canaliculus in the temporal bone and emerges to innervate specific areas of the external ear. The ABVN carries purely sensory (somatic afferent) fibres, unlike the main vagal trunk which carries a mix of sensory, motor, and autonomic fibres.

The specific area of the ear innervated by the ABVN is clinically important because it determines where taVNS electrodes should be placed. Cadaveric dissection and immunohistochemical studies have established that the cymba conchae (the upper part of the ear’s central cavity, above the entrance to the ear canal) has the densest and most consistent ABVN innervation. The tragus (the small flap of cartilage in front of the ear canal) receives some ABVN innervation but is also supplied by the auriculotemporal nerve (a branch of the trigeminal nerve), making it a less specific target.

The antihelix and the cavum conchae (lower part of the central cavity) receive mixed innervation from the ABVN and the great auricular nerve (from the cervical plexus). The ear lobe has no ABVN innervation and is commonly used as a sham stimulation site in clinical trials.

This anatomical specificity matters for taVNS. Stimulation of the cymba conchae produces activation patterns in the brainstem (specifically the nucleus tractus solitarius, the primary vagal sensory relay) that closely mirror those seen with implanted cervical VNS, as demonstrated by functional MRI studies. Stimulation of the ear lobe does not produce these patterns, confirming that the brainstem effects are mediated by the ABVN rather than by non-specific sensory input.

Arnold’s Nerve Cough Reflex

One of the earliest recognised clinical features of the ABVN is Arnold’s ear-cough reflex. In approximately 2 to 4 percent of the population, mechanical stimulation of the ear canal (such as inserting a cotton swab or an otoscope) triggers an involuntary cough. This occurs because the ABVN carries sensory information from the ear canal to the vagal sensory nuclei in the brainstem, where it activates the cough reflex pathway.

Arnold’s reflex is clinically significant in several ways. For ENT practitioners, it is a source of reflex coughing during ear examinations and procedures. More importantly, it demonstrates that stimulating the external ear can activate central vagal pathways, providing the anatomical rationale for taVNS. Some patients present with chronic unexplained cough that is actually mediated by ABVN irritation from earwax impaction, foreign bodies, or ear canal pathology.

Your local vagus nerve experts

Find a vagus nerve practitioner near you

Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.

Or browse by approach

The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)

taVNS delivers mild electrical pulses (typically 0.5 to 5 mA, at frequencies of 1 to 25 Hz, with pulse widths of 200 to 500 microseconds) to the ABVN via clip-on or adhesive electrodes placed on the ear. The most common stimulation targets are the cymba conchae and the tragus. Sessions typically last 15 to 60 minutes, though optimal parameters (frequency, intensity, duration, and stimulation site) remain under active investigation.

The proposed mechanism of action involves ABVN afferents projecting to the nucleus tractus solitarius (NTS), which then sends projections to the locus coeruleus (the brain’s primary norepinephrine source) and the dorsal raphe nucleus (the primary serotonin source). Through these projections, taVNS can modulate noradrenergic and serotonergic neurotransmission, which are systems implicated in depression, pain modulation, and seizure control. The NTS also projects to the dorsal motor nucleus of the vagus, which sends efferent parasympathetic fibres to the heart and viscera, potentially influencing heart rate and inflammatory pathways.

Clinical Evidence

Depression

taVNS for treatment-resistant depression has been studied in several randomised controlled trials. Results have been mixed but generally encouraging. A 2022 meta-analysis found that taVNS produced significant reductions in depression scores compared to sham stimulation, though effect sizes were modest. Implanted cervical VNS (which stimulates the main vagal trunk rather than the auricular branch) has been FDA-approved for treatment-resistant depression since 2005, and taVNS is being studied as a less invasive alternative. Clinical trials registered in 2025 and 2026 are evaluating taVNS for social anxiety disorder (NCT07772401) and other psychiatric conditions.

Epilepsy

Implanted cervical VNS has been FDA-approved as an adjunctive treatment for drug-resistant epilepsy since 1997. taVNS is being studied as a non-invasive alternative. Several pilot studies have reported reductions in seizure frequency with taVNS, but large-scale randomised data are limited. The approach is particularly attractive for paediatric patients and others who may not be candidates for implanted devices.

Pain

taVNS has been studied for migraine, chronic pain, and fibromyalgia. For migraine, gammaCore (a non-invasive cervical VNS device applied to the neck rather than the ear) has received FDA clearance, providing proof of concept for non-invasive vagal stimulation in headache. Auricular taVNS specifically has shown promise in pilot studies for chronic pain conditions, though the evidence base is still developing.

Inflammation

The anti-inflammatory potential of taVNS is based on the vagus nerve’s role in the cholinergic anti-inflammatory pathway. Small studies have reported reductions in inflammatory markers (TNF-alpha, IL-6, CRP) with taVNS. This is being explored for rheumatoid arthritis, inflammatory bowel disease, and post-surgical inflammation. SetPoint Medical’s implanted bioelectronic device for rheumatoid arthritis targets this pathway directly through the cervical vagus nerve and received FDA approval.

Other Applications

taVNS is also being investigated for tinnitus, post-stroke rehabilitation (paired with motor training), heart failure, atrial fibrillation, obesity, and disorders of consciousness. The breadth of applications reflects the vagus nerve’s influence across multiple organ systems, though for most of these conditions the evidence remains at the pilot study or early clinical trial stage.

Practical Considerations

taVNS is generally well-tolerated. The most common side effects are tingling, itching, or mild pain at the stimulation site, and occasional headache. Serious adverse events are rare. However, stimulation should be applied to the correct anatomical location (cymba conchae or tragus, not the ear lobe) and at appropriate parameters to ensure that the ABVN is actually being stimulated.

Consumer taVNS devices are available, but the quality, electrode design, and stimulation parameters vary significantly between products. Clinical-grade devices used in research trials (such as the NEMOS device, which received CE marking in Europe) differ substantially from many consumer products. Anyone considering taVNS should be aware that the evidence base is still developing for most conditions and that the optimal stimulation parameters have not been definitively established.

taVNS should not be used by people with implanted cardiac devices (pacemakers, defibrillators) without medical clearance, and it is generally applied to the left ear only. The right vagus nerve has stronger cardiac innervation, so right-sided stimulation carries a theoretical risk of cardiac effects, though this remains a precautionary recommendation rather than one based on documented adverse events.

How taVNS Compares to Implanted VNS

Implanted cervical VNS stimulates the main vagal trunk, which contains both afferent and efferent fibres. It delivers continuous or programmed stimulation 24 hours a day through a surgically implanted pulse generator and electrode. taVNS stimulates only the sensory auricular branch during discrete sessions. The stimulation reaches the brainstem through a different anatomical route (auricular afferents to the NTS rather than cervical trunk fibres to the NTS), but fMRI studies suggest significant overlap in the brainstem regions activated.

The advantages of taVNS are that it is non-invasive, relatively inexpensive, and carries no surgical risk. The disadvantages are that compliance depends on the patient performing regular sessions, the dose delivered may be less consistent than with an implanted device, and the evidence base for most conditions is less mature than for implanted VNS.

The auricular branch of the vagus nerve has opened up new possibilities for non-invasive neuromodulation. The My Vagus Nerve & Me eBook covers the anatomy of the vagus nerve, how different stimulation approaches work, and the science behind their therapeutic effects. Get My Vagus Nerve & Me eBook and understand the connection between your ear and your brain.

This article is for general information and is not medical advice. Talk to a qualified clinician before changing anything about your health or treatment. Read our medical disclaimer. Spotted an error? Let us know.